|Articles|October 1, 2000

October 2000
Volume 6
Issue 10

Follow-Up Among Women with an Abnormal Mammogram in an HMO: Is It Timely, Complete, and Efficient?

Author(s)Robert C. Burack, MD, MPH, Michael S. Simon, MD, MPH, Miron Stano, PhD

Download PDF: Follow-Up Among Women with an Abnormal Mammogram in an HMO: Is It Timely, Complete, and Efficient?

Articles in this issue

almost 26 years ago

Article

A Comparison of Medicare Fee-for-Service and a Group-Model HMO in the Inpatient Management and Long-Term Survival of Elderly Individuals with Syncope

almost 26 years ago

Article

Accrediting Organizations and Quality Improvement

almost 26 years ago

Article

Efficient Evaluation of Thyroid Nodules by Primary Care Providers and Thyroid Specialists

almost 26 years ago

Article

Therapeutic Substitution of Cimetidine for Nizatidine Was Not Associated with an Increase in Healthcare Utilization

almost 26 years ago

Article

Diagnosis of Skin Disease by Nondermatologists

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Follow-Up Among Women with an Abnormal Mammogram in an HMO: Is It Timely, Complete, and Efficient?

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access